BrainTale
Braintale develops and distributes diagnosis and prognosis tools for brain injured patients.
Total raised
€5.5M
€5,500,000
Funding rounds
2
Investors
2
distinct backers
Active since
2020-11
latest 2023-06
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 8y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-06-20 | Other | €4.5M | Capital Grand Est,MACSF | View deal → |
| 2020-11-10 | Other | €1.0M | — | View deal → |
Investors
2Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software